Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified everest criteria

Retina

Volumn 35, Issue 7, 2015, Pages 1375-1380

  Gemmy Cheung, Chui Ming ^a,b,c,d   Laude, Augustinus ^a,e   Wong, Wanling ^a,b,c,d   Mathur, Ranjana ^a,e   Mun Chan, Choi ^a,e   Wong, Edmund ^a,e   Wong, Doric ^a,e   Wong, Tien Yin ^a,b,c,e   Lim, Tock Han ^a,e  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COLOR FUNDUS PHOTOGRAPH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EYE DISEASE ASSESSMENT; FEMALE; FLASH FUNDUS CAMERA BASED FLUORESCEIN ANGIOGRAPHY; FUNDUS CAMERA; FUNDUS CAMERA BASED INDOCYANINE GREEN ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MODIFIED EVEREST CRITERIA; PHOTOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINA MACULOPATHY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBRETINAL FOCAL HYPERFLUORESCENCE; AREA UNDER THE CURVE; CHEMISTRY; CHOROIDAL NEOVASCULARIZATION; COMPARATIVE STUDY; FLUORESCENCE ANGIOGRAPHY; OBSERVER VARIATION; POLYPS; RECEIVER OPERATING CHARACTERISTIC; SUBRETINAL FLUID;

COLORING AGENT; INDOCYANINE GREEN;

AGED; AREA UNDER CURVE; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; OBSERVER VARIATION; POLYPS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBRETINAL FLUID;

EID: 84942569494     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000482     Document Type: Article

References (20)

1. Yannuzzi LA, Ciardella A, Spaide RF, et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997;115:478-485.
2. Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010;29:19-29.
3. Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 2010;24:483-490.
4. Ciadella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004;49:25-37.
5. Koh AH, Chen LJ, Chen SJ, et al. Polypoidal choroidal vasculopathy: Evidence-based guidelines for clinical diagnosis and treatment. Retina 2013;33:686-716.
6. Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy [in Japanese]. Nippon Ganka Gakkai Zasshi 2005;109:417-427.
7. Stanga PE, Lim JI, Hamilton P. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100-110.
8. Cohen SY, Dubois L, Quentel G, Gaudric A. Is indocyanine green angiography still relevant? Retina 2011;31:209-221.
9. Kokame GT. Polypoidal choroidal vasculopathy-an important diagnosis to make with therapeutic implications. Retina 2012; 32:1446-1448.
10. Leal S, Silva R, Figueira J, et al. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up. Retina 2010;30:1197-1205.
11. Silva RM, Figueira J, Cachulo ML, et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005;243:973-979.
12. Lafaut BA, Aisenbrey S, Van den Broecke C, et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000;20: 650-654.
13. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005;89:602-607.
14. Maruko I, Iida T, Saito M, Nagayama D. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:361-368.
15. Koh A, Lee WK, Chen LJ, et al. EVEREST STUDY: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012;32:1453-1456.
16. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportion. 3rd ed: Singapore: Wiley; 2003.
17. Cheung CMG, Lai TYY, Chen SJ, et al. Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoloscopy. Retina 2014. Epub ahead of print.
18. Ijima H, Imai M, Gohdo T, Tsukahara S. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999;127:301-305.
19. Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009;29:52-59.
20. De Salvo G, Vaz-Pereira S, Keane P, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2014. Epub ahead of print.